PMDA drug package insert
セパセルインテグラC−MAP
PMDA Prescription drug · SBカワスミ株式会社 · package insert Aug 28, 2026
Key facts
| Brand names | セパセルインテグラC−MAP |
|---|---|
| Nonproprietary names | ＣＰＤ液・ＭＡＰ液 |
| Companies | 製造販売元／SBカワスミ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 血液保存液C液（生物学的製剤基準）及び赤血球保存液MAP液 |
| Therapeutic category codes | 873339 |
| YJ codes | 333950GX1029 |
| Approval numbers | 21400AMZ00284000 |
| Package insert edition | 第3版 |
| Package insert date | Aug 28, 2026 |
| PMDA document key | 200162_333950GX1029_1 |
| PMDA company code | 200162 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: